A $1.3 Million Phase II Grant Awarded to Modulated Imaging

September 15, 2011

Modulated Imaging is proud to announce that we have been awarded a Small Business Technology Transfer Phase II Grant (2R42GM077713) from the National Institute of General Medical Sciences, part of the National Institutes of Health (NIH). This is a two year, $1.3 million grant that will work in collaboration with UC Irvine. The project, known as “Assessment of Reconstructive Surgical Flaps Using Spatially Resolved Tissue Oximager,” builds off of the success of our Phase I Grant on the same project, and will assess the viability of Spatial Frequency Domain Imaging (SFDI) to determine the health status of tissue reconstruction flaps.

Small Business Innovation Research Grants (SBIR) is a Congressional program coordinated by the Small Business Association, to encourage partnerships between small businesses and nonprofit research institutions. Grants are highly competitive. Proposals are judged by a team of experts, who evaluate and compare proposals on their potential impact, feasibility, and the abilities of the research team.

SFDI is a next-generation tissue imaging technology that uses visible and near-infrared light to measure blood, oxygen, melanin, and other chromophores, while also visualizing many sub-dermal structures. Unlike many other imaging systems that use potentially harmful radiation or strong magnetic fields, SFDI uses only safe light waves.

Modulated Imaging was founded to commercialize this breakthrough SFDI technology, and was spun out of the Photonic Incubator within the Beckman Laser Institute at UC Irvine. Since its inception, Modulated Imaging has been backed by a passionate team who believes in the potential of SFDI as a revolutionary tissue imaging technology for research in many fields, medical diagnostics, and therapy monitoring.